RESMED INC — Director's Dealing 2017

May 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-05-03

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-03	ResMed Common Stock	M	6365	$27.58	Acquired	84261	Direct
2017-05-03	ResMed Common Stock	S	6365	$69.549	Disposed	77896	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-03	ResMed Common Stock Options	$27.58	M	6365	Disposed	2018-11-16	ResMed Common Stock (6365)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $69.45 to $69.63. The price reported above reflects the weighted average sale price.

F3: Represents date options first became exercisable. Options vest 1/4 per year.